NCT04948463 2025-12-24
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
Clinical Trials
24 trialsNCT04637464 2025-04-09
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
Rigshospitalet, Denmark
Phase NA Completed
NCT05584930 2024-12-30
CluPPFeN
University Hospital, Angers
Phase NA Completed
NCT03233776 2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2 Completed
NCT04099901 2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2 Completed
NCT03104595 2023-08-15
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer
Enzychem Lifesciences Corporation
Phase 1/2 Completed
NCT04477616 2023-02-23
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT02728596 2022-10-20
TrACER
SWOG Cancer Research Network
Phase NA Completed
NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
NCT03429387 2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA Completed
NCT03087227 2022-05-09
NEUTROSIS
University of Paris 13
Phase NA Completed
NCT04466137 2022-02-09
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 3 Completed
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT00536081 2019-11-06
Various G-CSF Regimens to Prevent Infection During Chemotherapy
Academisch Ziekenhuis Maastricht
Phase 3 Completed
NCT04000711 2019-06-27
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
Hospital Infantil de Mexico Federico Gomez
Phase NA Completed
NCT02005458 2018-07-17
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 2 Completed
NCT00911170 2017-12-29
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
Phase 3 Completed
NCT01569087 2016-12-05
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
Biocad
Phase 2 Completed
NCT02104830 2016-10-24
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Biocad
Phase 3 Completed
NCT02119715 2014-04-22
A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
NCT01611051 2013-01-08
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT00035425 2009-12-01
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Pfizer
Phase 3 Completed
NCT00454272 2009-03-06
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Sanofi
Phase 4 Completed
NCT00129688 2005-09-23
Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
Khon Kaen University
Phase NA Completed